IBM & Moderna Collaborate for Better COVID-19 Vaccine Management

IBM & Moderna Collaborate for Better COVID-19 Vaccine Management
share Share

The vaccine manufacturer Moderna and IBM, a technology company, will work together on implementation of technologies such as artificial intelligence, blockchain and hybrid cloud, to improve COVID-19 vaccine management in the U.S.

 

You might also like: An interview with European and U.S. experts about the need for global monitoring of vaccine use as well as its safety and effectiveness. Learn more

 

The collaboration will first be testing open, standardised, technology-enabled approaches to vaccine distribution that would allow for more efficient supply management and a near real-time monitoring of vaccine administration. With this, the companies are looking into the possibilities of secure and seamless data sharing between various stakeholders, from authorities to providers to individuals.

 

Initially the focus will be on:

  • Solutions for tracing individual batches of vaccine at all stages, from manufacturing to administration, and avoiding potential disruptions in the supply chain.
  • IBM’s blockchain-based Digital Health Pass for health credentials verification for work, travel, shopping and other types of activities. The solution incorporates data on COVID-19 test results, vaccination records, temperature checks, etc.

 

Moderna’s two-dose mRNA vaccine has been approved for emergency use in the U.S. and in Europe.

 

Source: IBM

Image credit: carmengabriela via iStock

«« What Were Outcomes in COVID-19 Patients in U.S.?


EMA: Developments for Sputnik V and Janssen COVID-19 Vaccines »»

Published on : Fri, 5 Mar 2021



Related Articles
What Were Outcomes in COVID-19 Patients in U.S.?

Almost 1 in 3 COVID-19 patients admitted to ICU in U.S. hospitals died, although the mortality rate decreased over the... Read more

The European Medicines Agency’s (EMA) announced today that the single dose Covid-19 vaccine has been approved for use in individuals... Read more

Perfect Storm for AstraZeneca’s COVID-19 Vaccine in EU

AstraZeneca’s COVID-19 vaccine has been the centre of attention in Europe over the past few days. Several countries has... Read more

IBM, COVID-19, Moderna, COVID-19 vaccines’ supply chain, COVID-19 vaccine IBM & Moderna Collaborate for Better COVID-19 Vaccine Management

No comment


Please login to leave a comment...

Highlighted Products